Evidence map›Paper›PMID 26172442›Full record

ArticlePloS one2015

Allelic Variants in Arhgef11 via the Rho-Rock Pathway Are Linked to Epithelial-Mesenchymal Transition and Contributes to Kidney Injury in the Dahl Salt-Sensitive Rat.

Zhen Jia, Ashley C Johnson, Xuexiang Wang, Zibiao Guo, Albert W Dreisbach, Jack R Lewin, Patrick B Kyle, Michael R Garrett

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Loss ofHypertension (Dallas, Tex. : 1979) · 2020
    Article
  9. Review
  10. Article
  11. Article
  12. Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology.Laboratory investigation; a journal of technical methods and pathology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhen JiaDepartment of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS, United States of America.
Ashley C JohnsonDepartment of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS, United States of America.
Xuexiang WangDepartment of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS, United States of America.
Zibiao GuoDepartment of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS, United States of America; Molecular and Genomics Core Facility, University of Mississippi Medical Center, Jackson, MS, United States of America.
Albert W DreisbachDepartment of Medicine (Nephrology), University of Mississippi Medical Center, Jackson, MS, United States of America.
Jack R LewinDepartment of Pathology, University of Mississippi Medical Center, Jackson, MS, United States of America.
Patrick B KyleDepartment of Pathology, University of Mississippi Medical Center, Jackson, MS, United States of America.
Michael R GarrettDepartment of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS, United States of America; Department of Medicine (Nephrology), University of Mississippi Medical Center, Jackson, MS, United States of America.

Funding

Training and Mentoring Core P20GM103476 · NIGMS · UNIVERSITY OF SOUTHERN MISSISSIPPI · PI MICHAEL R GARRETT · 2012 to 2026
$60.2M
The role of leptin in autoimmune-associated hypertensionP20GM104357 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI TAYLOR, ERIN BASSFORD · 2013 to 2022
$23.4M
Center for Psychiatric NeuroscienceP30GM103328 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI STOCKMEIER, CRAIG ALLEN · 2013 to 2017
$5.5M
Genetics of Renal End Organ Damage in HypertensionR01HL094446 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI GARRETT, MICHAEL R · 2009 to 2013
$1.8M
NHLBI NIH HHS HL094446NHLBI NIH HHS R01 HL094446NIGMS NIH HHS P20 GM103476NIGMS NIH HHS P20GM103476NIGMS NIH HHS P20 GM104357NIGMS NIH HHS P20GM104357NIGMS NIH HHS P30 GM103328NIGMS NIH HHS P30GM103328
6 · The paper itself

Abstract

Previously, genetic analyses identified that variants in Arhgef11 may influence kidney injury in the Dahl salt-sensitive (S) rat, a model of hypertensive chronic kidney disease. To understand the potential mechanism by which altered expression and/or protein differences in Arhgef11 could play a role in kidney injury, stably transduced Arhgef11 knockdown cell lines as well as primary cultures of proximal tubule cells were studied. Genetic knockdown of Arhgef11 in HEK293 and NRK resulted in reduced RhoA activity, decreased activation of Rho-ROCK pathway, and less stress fiber formation versus control, similar to what was observed by pharmacological inhibition (fasudil). Primary proximal tubule cells (PTC) cultured from the S exhibited increased expression of Arhgef11, increased RhoA activity, and up regulation of Rho-ROCK signaling compared to control (small congenic). The cells were also more prone (versus control) to TGFβ-1 induced epithelial-mesenchymal transition (EMT), a hallmark feature of the development of renal interstitial fibrosis, and characterized by development of spindle shape morphology, gene expression changes in EMT markers (Col1a3, Mmp9, Bmp7, and Ocln) and increased expression of N-Cadherin and Vimentin. S derived PTC demonstrated a decreased ability to uptake FITC-albumin compared to the small congenic in vitro, which was confirmed by assessment of albumin re-uptake in vivo by infusion of FITC-albumin and immunofluorescence imaging. In summary, these studies suggest that genetic variants in the S form of Arhgef11 via increased expression and/or protein activity play a role in promoting kidney injury in the S rat through changes in cell morphology (Rho-Rock and/or EMT) that impact the function of tubule cells.

Indexed as

AllelesAnimalsAnimals, CongenicCell LineDisease Models, AnimalEpithelial-Mesenchymal TransitionGene Knockdown TechniquesGenetic VariationGuanine Nucleotide Exchange FactorsHEK293 CellsHumansKidney Tubules, ProximalMalePlakinsRatsRats, Inbred DahlARHGEF11 protein, humanArhgef11 protein, ratGuanine Nucleotide Exchange FactorsPlakinsrho-Associated Kinasesrho GTP-Binding ProteinsRho Guanine Nucleotide Exchange Factors

Identifiers

PMID26172442
PMCPMC4501567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.